|
Sep 28
|
Ionis (IONS) Inks New Deal With Roche to Develop Novel RNA Drugs
|
|
Aug 25
|
Pharma Stock Roundup: PFE Gets Nod for RSV Vaccine, J&J Finalizes Kenvue Separation
|
|
Aug 24
|
Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak
|
|
Aug 24
|
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
|
|
Aug 23
|
Why Roche's Accidental Cancer Update Boosted Several Rivals By As Much As 22%
|
|
Aug 23
|
Watertown biotech shares spike after accidental data publication at Roche
|
|
Aug 23
|
Is Sarepta Therapeutics Stock a Top Growth Vehicle?
|
|
Aug 23
|
25 Most Innovative Companies Of All Time
|
|
Aug 23
|
Roche inadvertently publishes positive results from lung cancer drug study
|
|
Aug 23
|
Genentech Provides Update on Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer
|
|
Aug 23
|
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III Skyscraper-01 study in PD-L1-high metastatic non-small cell lung cancer
|
|
Jul 21
|
CHMP recommends Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
|
|
Jul 20
|
New clinical and real-world data for Roche’s Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss
|
|
Jul 20
|
New Clinical and Real-World Data for Genentech’s Vabysmo at ASRS Reveal Improved Outcomes for People With Two Leading Causes of Vision Loss
|
|
Jul 19
|
Roche to showcase next-generation diagnostic solutions at the American Association of Clinical Chemistry 2023 Clinical Lab Expo
|
|
Jul 19
|
The Zacks Analyst Blog Highlights Roche, Fomento Economico Mexicano, Advanced Micro Devices, Union Pacific and Mondelez International
|
|
Jul 18
|
Why Novartis Stock Spiked Today
|
|
Jul 18
|
Q2 Earnings Scorecard and Analyst Reports for Roche, AMD & Others
|
|
Jul 18
|
Lilly's (LLY) Donanemab Slows Alzheimer's Disease Progression
|
|
Jul 17
|
2 Nasdaq Stocks That Could Soar This Week
|